Group I | Group II | p value | |||
---|---|---|---|---|---|
(n = 247) | (n = 142) | ||||
Age | 56.5 ± 15.7 | 63.4 ± 15.2 | <0.001* | *1 | |
Male | 89 (36.0 %) | 61 (43.0 %) | 0.195 | *2 | |
SF-8 norm-based mean score | PF | 49.9 ± 6.7 | 48.2 ± 7.2 | 0.001* | |
RP | 50.0 ± 6.4 | 48.5 ± 6.9 | 0.008* | ||
BP | 52.8 ± 7.8 | 50.1 ± 8.2 | 0.001* | ||
GH | 50.0 ± 6.2 | 50.2 ± 6.8 | 0.596 | *3 | |
VT | 51.2 ± 6.0 | 51.1 ± 6.1 | 0.844 | ||
SF | 50.8 ± 7.4 | 48.8 ± 8.6 | 0.016* | ||
RE | 50.1 ± 5.2 | 48.3 ± 7.5 | 0.041* | ||
MH | 50.6 ± 6.0 | 49.7 ± 7.3 | 0.521 | ||
PCS | 49.6 ± 6.7 | 48.0 ± 6.3 | 0.006* | *1 | |
MCS | 49.7 ± 6.0 | 48.8 ± 7.8 | 0.659 |